Veterinární Medicína (Apr 2022)

Canine adipose tissue-derived mesenchymal stem cell therapy in a dog with renal Fanconi syndrome

  • An JH,
  • Kim KB,
  • Kwon SC,
  • Kim HJ,
  • Ryu MO,
  • Oh YI,
  • Ahn JO,
  • Youn HY

DOI
https://doi.org/10.17221/213/2020-VETMED
Journal volume & issue
Vol. 67, no. 4
pp. 206 – 211

Abstract

Read online

Renal Fanconi syndrome (RFS) affects the proximal tubular resorption in the nephrons. This causes excessive loss of key solutes through the urine. In a canine patient, we successfully managed the renal tubular acidosis and proteinuria caused by RFS via transplantation of canine adipose tissue-derived mesenchymal stem cells (cAT-MSCs). cAT-MSCs were administered ten times at intervals of 2-4 weeks. The post-therapy check-up revealed that the cAT-MSC treatment improved the renal tubular acidosis and proteinuria. Hence, a cAT-MSC transplant may be considered as an adjuvant therapy in veterinary medicine to initiate and maintain relief of RFS-induced acidosis and proteinuria.

Keywords